ADXS · Categories · Form 4

ADXS - SEC Form 4 insider transactions

Advaxis, Inc. (ADXS) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for ADXS

• 820d
  SEC Form 4 filed by Israel Biotech Fund I, L.P.

  4 - Ayala Pharmaceuticals, Inc. (0001100397) (Issuer)
• 842d
  Israel Biotech Fund I, L.P. exercised 27,847,159 shares at a strike of $0.40 and covered exercise/tax liability with 5,294,486 shares (SEC Form 4)

  4 - Ayala Pharmaceuticals, Inc. (0001100397) (Issuer)
• 926d
  SEC Form 4 filed by Israel Biotech Fund I, L.P.

  4 - Ayala Pharmaceuticals, Inc. (0001100397) (Issuer)
• 955d
  Amoon Growth Fund Limited Partnership disposed of 0 shares (SEC Form 4)

  4 - Ayala Pharmaceuticals, Inc. (0001100397) (Issuer)
• 979d
  SEC Form 4 filed by Israel Biotech Fund I, L.P. (Amendment)

  4/A - Ayala Pharmaceuticals, Inc. (0001100397) (Issuer)
• 996d
  SEC Form 4 filed by Israel Biotech Fund I, L.P.

  4 - Ayala Pharmaceuticals, Inc. (0001100397) (Issuer)
• 1227d
  SEC Form 4: Sidransky David was granted 46 shares

  4 - Ayala Pharmaceuticals, Inc. (0001100397) (Issuer)
• 1227d
  SEC Form 4 filed by Goldberg Murray A

  4 - Ayala Pharmaceuticals, Inc. (0001100397) (Issuer)
• 1227d
  SEC Form 4 filed by Bisker-Leib Vered

  4 - Ayala Pharmaceuticals, Inc. (0001100397) (Issuer)
• 1227d
  SEC Form 4 filed by Spiegel Robert J.

  4 - Ayala Pharmaceuticals, Inc. (0001100397) (Issuer)

Other ADXS categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends